Short answer
Prioritize demonstrable user benefit and long-term value over superficial innovation when developing and marketing new products, especially in high-stakes sectors like healthcare.
- Field
- Innovation & Markets
- Source
- Academic Publication (2021)
- Method
- Comparative analysis and retrospective study
- Evidence
- Strong effect
New, high-cost cancer treatments often fail to demonstrate significant improvements in patient survival or quality of life, questioning their true value proposition. This innovation & markets research insight is drawn from a 2021 study published in Academic Publication. Using Comparative analysis and retrospective study, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Prioritize demonstrable user benefit and long-term value over superficial innovation when developing and marketing new products, especially in high-stakes sectors like healthcare.
Innovative Cancer Treatments Show Limited Added Value Despite Soaring Costs
New, high-cost cancer treatments often fail to demonstrate significant improvements in patient survival or quality of life, questioning their true value proposition.
Academic Publication · 2021
Key Findings
- 01Many innovative cancer treatments did not significantly prolong patient lives or improve quality of life.
- 02The cost of these innovative treatments increased dramatically, from €140 million in 2007 to over €1 billion in 2019.
- 03A more transparent system emphasizing real patient added value is recommended for resource allocation.
Application
Design takeaway
Prioritize demonstrable user benefit and long-term value over superficial innovation when developing and marketing new products, especially in high-stakes sectors like healthcare.
How to apply
When developing a new medical device or therapeutic approach, conduct rigorous outcome studies that directly measure improvements in patient survival and well-being, and benchmark these against existing treatments and their costs.
Project actions
- 01When designing a product, think about what real problem it solves and how much better it makes things for the user.
- 02Don't just make something new; make something that is demonstrably better and worth the cost.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Large-scale data analysis over a significant time period.
- +Direct comparison of treatment outcomes with financial expenditure.
Limitations
The study's findings are specific to cancer treatments in Belgium and may not apply to all medical innovations or other industries. Measuring 'quality of life' can be challenging.
Reliability & validity
The study's reliability is supported by its use of extensive real-world data and a comparative approach. Validity is enhanced by focusing on objective measures like survival rates, though the subjective nature of 'quality of life' introduces potential limitations.
Think critically
How can designers and engineers proactively ensure their innovations provide demonstrable 'added value' to users and society, rather than just incremental improvements or novel features?
Design Principles
"Value-driven innovation: Ensure that new designs deliver measurable and significant improvements to users and stakeholders, justifying their cost and resource investment."
This research highlights a critical disconnect between the perceived innovation of medical treatments and their tangible benefits. For designers and engineers developing new products, understanding the true 'added value' beyond novelty is crucial for market acceptance and responsible resource allocation.
What This Means for Your Design
New medicines for cancer are very expensive, but they don't always help patients live longer or feel better as much as we'd hope.
How to use in your project
- 1.Use this study to justify the need for thorough user testing and validation of your design's effectiveness.
- 2.Reference this to support arguments for prioritizing functional benefits and user experience over purely aesthetic or novel features in your design project.
Add to My Project
Quick Cite
Paragraph starter
This research highlights that innovation alone does not guarantee added value, as demonstrated by the high cost and limited impact of novel cancer treatments. This underscores the importance of rigorously evaluating a design's tangible benefits, such as improved user outcomes and efficiency, against its development and market costs, rather than solely focusing on novelty or technological advancement.
Source
Academic Publication
Do innovative medicines against cancer always have a real added value?
journal · 2021
View sourceQuestions About This Research
- What does the research say about innovative cancer treatments show limited added value despite soaring costs?
- Prioritize demonstrable user benefit and long-term value over superficial innovation when developing and marketing new products, especially in high-stakes sectors like healthcare. Evidence: Academic Publication (2021).
- Why does "Innovative Cancer Treatments Show Limited Added Value Despite Soaring Costs" matter for design?
- This research highlights a critical disconnect between the perceived innovation of medical treatments and their tangible benefits. For designers and engineers developing new products, understanding the true 'added value' beyond novelty is crucial for market acceptance and responsible resource allocation.
- How can designers apply this research?
- Prioritize demonstrable user benefit and long-term value over superficial innovation when developing and marketing new products, especially in high-stakes sectors like healthcare.
- What were the main findings?
- Many innovative cancer treatments did not significantly prolong patient lives or improve quality of life.. The cost of these innovative treatments increased dramatically, from €140 million in 2007 to over €1 billion in 2019.. A more transparent system emphasizing real patient added value is recommended for resource allocation.
- What research method was used?
- Comparative analysis and retrospective study.
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2021 journal from Academic Publication.
- What should I do differently in my next project?
- When developing a new medical device or therapeutic approach, conduct rigorous outcome studies that directly measure improvements in patient survival and well-being, and benchmark these against existing treatments and their costs.
- What are the limitations?
- The study focused on specific cancer types and a single geographical region (Belgium), which may limit generalizability. The definition and measurement of 'quality of life' can be subjective.